AptarGroup, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
February 08, 2024 at 05:05 pm EST
Share
AptarGroup, Inc. reported earnings results for the fourth quarter and full year ended December 31, 2023. For the fourth quarter, the company reported sales was USD 838.48 million compared to USD 795.91 million a year ago. Net income was USD 62.36 million compared to USD 59 million a year ago. Basic earnings per share from continuing operations was USD 0.95 compared to USD 0.9 a year ago. Diluted earnings per share from continuing operations was USD 0.93 compared to USD 0.89 a year ago.
For the full year, sales was USD 3,487.45 million compared to USD 3,322.25 million a year ago. Net income was USD 284.49 million compared to USD 239.29 million a year ago. Basic earnings per share from continuing operations was USD 4.34 compared to USD 3.66 a year ago. Diluted earnings per share from continuing operations was USD 4.25 compared to USD 3.59 a year ago.
AptarGroup, Inc. is engaged in designing and manufacturing of drug and consumer product dosing, dispensing and protection technologies. The Company serves various end markets, including pharmaceutical, beauty, food, beverage, personal care and home care. The Company operates through three segments: Aptar Pharma, Aptar Beauty and Aptar Closures. Aptar Pharma segment supplies nasal drug delivery spray pumps and metered dose inhaler valves (MDIs) to the pharmaceutical and healthcare markets worldwide and supplies elastomer for injectable primary packaging components worldwide. The segment also provides services designed to accelerate and de-risk the development and regulatory approvals of drugs using drug delivery devices. The Aptar Beauty segment sells a variety of pumps, airless systems and valves to the fragrance, color cosmetics, facial skincare, personal care and home care markets. Aptar Closures segment primarily sells dispensing closures.